Brief: Anaptysbio Reports First Quarter 2023 Financial Results
11/05/2023 21:28
May 11 (Reuters) - AnaptysBio Inc ANAB.O :
* ANAPTYSBIO ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES PIPELINE UPDATE
* ANAPTYSBIO INC - REITERATING CASH RUNWAY THROUGH YEAR-END
2026
WITH EXPECTED YEAR-END 2023 CASH AND INVESTMENTS OF $370 - $385
MILLION
* ANAPTYSBIO INC - QTRLY LOSS PER SHARE $1.58
Source text for Eikon: ID:nGNX2GtHkF
Further company coverage: ANAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged